EUVIMEDEUVIMED entdecken
Crossref

Mifepristone achieves tumor suppression and ferroptosis through PR/p53/HO1/GPX4 axis in meningioma cells

Qin Dai, Jinfei Wei, Ziwei Li, Ting Li, Yenan Fang, Xinyu Li, Bingyan Shen, Qiqi Xie, Min Wang, Wencan Wu

Journal of Neuro-Oncology · 2025

DOI: 10.1007/s11060-024-04918-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Qin Dai und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. Hauptthemen laut MEDLINE: Meningioma, Ferroptosis, Mifepristone, Meningeal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, China, the Science and Technology Plan Project of Wenzhou Municipality, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study explores the effects of mifepristone on the proliferation, motility, and invasion of malignant and benign meningioma cells, aiming to identify mifepristone-sensitive types and investigate the underlying molecular mechanisms. METHODS: IOMM-Lee and HBL-52 meningioma cells were treated with 0, vehicle control (VC), 5, 10, 20, 40, and 80 μM of mifepristone for 12, 24, 48, 72, and 96 h. Proliferation was assessed via CCK8 assay, while motility and invasion were measured using wound scratch and transwell assays. RNA sequencing and RT-PCR were used to analyze gene expression changes. RESULTS: Mifepristone inhibited proliferation, motility, and invasion in both IOMM-Lee and HBL-52 cells in a dose- and time-dependent manner. RNA sequencing showed up-regulated genes significantly enriched in the ferroptosis pathway in both cell lines, confirmed by increased p53 and HO1 expression, decreased GPX4 expression, lipid peroxidation, Fe2+ accumulation, and ROS release. Immunofluorescence staining and RT-PCR also revealed a corresponding decrease in mifepristone-related progesterone receptor expression. CONCLUSION: Mifepristone induces ferroptosis in meningioma cells via the PR/p53/HO1/GPX4 axis, suggesting its potential as a treatment for ferroptosis-sensitive meningiomas. It also supplies new clues regarding ferroptosis as a treatment entry point for meningiomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaFerroptosisMifepristoneMeningeal NeoplasmsHumansPhospholipid Hydroperoxide Glutathione PeroxidaseTumor Suppressor Protein p53Cell ProliferationCell MovementHeme Oxygenase-1Receptors, ProgesteroneCell Line, TumorGene Expression Regulation, NeoplasticSignal Transduction

Stichwörter der Autor:innen

FerroptosisMeningiomaMifepristoneProgesterone receptor

Substanzen

MifepristonePhospholipid Hydroperoxide Glutathione PeroxidaseTumor Suppressor Protein p53Heme Oxygenase-1Receptors, ProgesteroneTP53 protein, humanHMOX1 protein, human

Autor:innen und Institutionen

  • National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
  • State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
  • National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. 18068520016@eye.ac.cn.
  • State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. 18068520016@eye.ac.cn.
  • National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. wuwencan@wmu.edu.cn.
  • State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. wuwencan@wmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province, China
  • the Science and Technology Plan Project of Wenzhou Municipality, China
  • the Eye Hospital of Wenzhou Medical University
  • the National Key Research and Development Program of China

Zitieren

APA

Dai, Q., Wei, J., Li, Z., Li, T., Fang, Y., Li, X., Shen, B., Xie, Q., Wang, M., & Wu, W. (2025). Mifepristone achieves tumor suppression and ferroptosis through PR/p53/HO1/GPX4 axis in meningioma cells. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04918-6

Vancouver

Dai Q, Wei J, Li Z, Li T, Fang Y, Li X, et al. Mifepristone achieves tumor suppression and ferroptosis through PR/p53/HO1/GPX4 axis in meningioma cells. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-024-04918-6

BibTeX
@article{Dai2025,
  author = {Dai, Qin and Wei, Jinfei and Li, Ziwei and Li, Ting and Fang, Yenan and Li, Xinyu and Shen, Bingyan and Xie, Qiqi and Wang, Min and Wu, Wencan},
  title = {Mifepristone achieves tumor suppression and ferroptosis through PR/p53/HO1/GPX4 axis in meningioma cells},
  journal = {Journal of Neuro-Oncology},
  year = {2025},
  doi = {10.1007/s11060-024-04918-6}
}
Kostenlos starten →